Skip to main content
WB

www.benewill.com

Inactive

The startup develops drugs and vaccines targeting infectious diseases through research in viral protein structure biology and antibody epitopes. By focusing on the mechanisms of infection and immune response, the company aims to create effective therapeutic antibodies and tumor vaccines for improved treatment outcomes.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • The startup develops drugs and vaccines targeting infectious diseases through research in viral protein structure biology and antibody epitopes. By focusing on the mechanisms of infection and immune response, the company aims to create effective therapeutic antibodies and tumor vaccines for improved treatment outcomes.
This profile is AI-generated and may contain inaccuracies.